Editorial: Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: A paradigm shift

Journal of Thoracic Oncology

Volumn 5, Issue 4, 2010, Pages 411-414

  Travis, William D ^a   Rekhtman, Natasha ^a   Riley, Gregory J ^a   Geisinger, Kim R ^b   Asamura, Hisao ^c   Brambilla, Elisabeth ^d   Garg, Kavita ^e   Hirsch, Fred R ^f   Noguchi, Masayuki ^g   Powell, Charles A ^h   Rusch, Valerie W ^a   Scagliotti, Giorgio ⁱ   Yatabe, Yasushi ^j  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

^c NATIONAL CANCER CENTER   (Japan)

^d GRENOBLE UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO CANCER CENTER   (United States)

^g UNIVERSITY OF TSUKUBA   (Japan)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ UNIVERSITY OF TURIN   (Italy)

^j AICHI CANCER CENTER HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED CANCER; CYTODIAGNOSIS; CYTOLOGY; EDITORIAL; HISTOPATHOLOGY; HUMAN; LUNG BIOPSY; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PRIORITY JOURNAL; TUMOR CLASSIFICATION; BIOPSY; CHEMISTRY; LUNG TUMOR; NOTE; PATHOLOGY;

TUMOR MARKER;

BIOPSY; CYTODIAGNOSIS; HUMANS; LUNG NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77950999338     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3181d57f6e     Document Type: Editorial

References (26)

1. Nicholson AG, Gonzalez D, Shah P, et al. Refining the diagnosis and EGFR status of non-small cell carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6 and P63 and EGFR mutation analysis. J Thorac Oncol (in press).
2. Loo PS, Thomas SC, Nicolson MC, et al. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol (in press).
3. World Health Organization. Histological Typing of Lung Tumours. Geneva: World Health Organization, 1967.
4. World Health Organization. Histological Typing of Lung Tumors. Geneva: World Health Organization, 1981.
5. Travis WD, Colby TV, Corrin B, et al. Histological Typing of Lung and Pleural Tumors. Berlin: Springer, 1999.
6. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Pathology and Genetics: Tumours of the Lung, Pleura, Thymus and Heart. Lyon, France: IARC Press, 2004.
7. Hirsch FR, Spreafico A, Novello S, et al. The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review. J Thorac Oncol 2008;3:1468-1481.
8. Johnson DH, Fehrenbacher L, Novotny WF, et al. Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancer. J Clin Oncol 2004;22:2184-2191. (Pubitemid 41095154)
9. Scagliotti G, Hanna N, Fossella F, et al. The differential efficacy of pemetrexed according to NSCLC histology: a review of two Phase III studies. Oncologist 2009;14:253-263.
10. Scagliotti GV, Parikh P, von Pawel J, et al. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy- naive patients with advanced-stage non-small-cell lung cancer. J Clin Oncol 2008;26:3543-3551.
11. Ciuleanu T, Brodowicz T, Zielinski C, et al. Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: a randomised, double-blind, phase 3 study. Lancet 2009;374:1432-1440.
12. Mok TS, Wu YL, Thongprasert S, et al. Gefitinib or carboplatin- paclitaxel in pulmonary adenocarcinoma. N Engl J Med 2009;361:947-957.
13. Roggli VL, Vollmer RT, Greenberg SD, et al. Lung cancer heterogeneity: a blinded and randomized study of 100 consecutive cases. Hum Pathol 1985;16:569-579.
14. Cataluna JJ, Perpina M, Greses JV, et al. Cell type accuracy of bronchial biopsy specimens in primary lung cancer. Chest 1996;109:1199-1203. (Pubitemid 26145656)
15. Fujii T, Dracheva T, Player A, et al. A preliminary transcriptome map of non-small cell lung cancer. Cancer Res 2002;62:3340-3346. (Pubitemid 34651374)
16. Bhattacharjee A, Richards WG, Staunton J, et al. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci USA 2001;98:13790-13795. (Pubitemid 33115977)
17. Takeuchi T, Tomida S, Yatabe Y, et al. Expression profile-defined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol 2006;24:1679-1688. (Pubitemid 46622139)
18. Kosaka T, Yatabe Y, Endoh H, et al. Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res 2004;64:8919-8923. (Pubitemid 39665498)
19. Tam IY, Chung LP, Suen WS, et al. Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res 2006;12:1647-1653.
20. Ring BZ, Seitz RS, Beck RA, et al. A novel five-antibody immunohistochemical test for subclassification of lung carcinoma. Mod Pathol 2009;22:1032-1043.
21. Monica V, Ceppi P, Righi L, et al. Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung. Mod Pathol 2009;22:709-717.
22. Bishop JA, Sharma R, Illei PB. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma. Hum Pathol 2010;41: 20-25.
23. Lebanony D, Benjamin H, Gilad S, et al. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. J Clin Oncol 2009;27:2030-2037.
24. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th Ed. Lyon: International Agency of Research on Cancer, 2008.
25. Fletcher CD, Unni KK, Mertens F. Pathology and Genetics: Tumours of Soft Tissue and Bone. Lyon: International Agency for Research on Cancer Press, 2002.
26. Travis WD, Brambilla E, Noguchi M, et al. The new IASLC/ATS/ERS international multidisciplinary lung adenocarcinoma classification. J Thorac Oncol (in press).